Assessment of damage in Takayasu arteritis in the clinic: an idea whose time has come!

Affiliations

Editorial

Durga Prasanna Misra. Rheumatology (Oxford). 2025.

. 2025 Feb 1;64(2):393-395.

doi: 10.1093/rheumatology/keae499.

¹ Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India.

No abstract available

Comment on

Assessment of damage in Takayasu's arteritis.
Kermani TA, Sreih AG, Cuthbertson D, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Rhee RL, Seo P, Warrington KJ, Merkel PA. Kermani TA, et al. Rheumatology (Oxford). 2025 Feb 1;64(2):682-689. doi: 10.1093/rheumatology/keae333. Rheumatology (Oxford). 2025. PMID: 38885370 Free PMC article.
Impact of conventional and biological disease-modifying anti-rheumatic drugs on arterial lesions in Takayasu arteritis.
Bletry D, Meyblum L, Desseaux K, Vautier M, Chiche L, Le Joncour A, Redheuil A, Roux C, Cacoub P, Gaudric J, Biard L, Saadoun D. Bletry D, et al. Rheumatology (Oxford). 2025 Feb 1;64(2):675-681. doi: 10.1093/rheumatology/keae331. Rheumatology (Oxford). 2025. PMID: 38970381